Inovio Pharmaceuticals (NASDAQ:INO) Price Target Cut to $8.00
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) had its price target reduced by analysts at Royal Bank of Canada from $11.00 to $8.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target would indicate a potential downside […]
More Stories
William Blair Reiterates “Market Perform” Rating for Kezar Life Sciences (NASDAQ:KZR)
William Blair reaffirmed their market perform rating on shares of Kezar Life Sciences (NASDAQ:KZR – Free Report) in a research...
Empirical Finance LLC Acquires 471 Shares of The Kroger Co. (NYSE:KR)
Empirical Finance LLC lifted its holdings in The Kroger Co. (NYSE:KR – Free Report) by 2.1% during the 3rd quarter,...
Starbucks’ (SBUX) “Sell” Rating Reiterated at Redburn Atlantic
Redburn Atlantic reissued their sell rating on shares of Starbucks (NASDAQ:SBUX – Free Report) in a research report report published...
Nutanix (NASDAQ:NTNX) Research Coverage Started at Oppenheimer
Oppenheimer began coverage on shares of Nutanix (NASDAQ:NTNX – Free Report) in a research report released on Wednesday, MarketBeat reports....
Phillips Edison & Company, Inc. (NASDAQ:PECO) Upgraded by Wolfe Research to “Outperform” Rating
Wolfe Research upgraded shares of Phillips Edison & Company, Inc. (NASDAQ:PECO – Free Report) from a peer perform rating to...
High Liner Foods (TSE:HLF) Reaches New 12-Month High – Still a Buy?
High Liner Foods Inc (TSE:HLF – Get Free Report)’s share price hit a new 52-week high on Thursday . The...